Cite
Imai H, Shimizu K, Kawashima O, et al. Clinical Significance of Various Drug-Sensitivity Markers in Patients with Surgically Resected Pulmonary Pleomorphic Carcinoma. Cancers (Basel). 2019;11(11)doi: 10.3390/cancers11111636.
Imai, H., Shimizu, K., Kawashima, O., Endoh, H., Imaizumi, K., Goto, Y., Kamiyoshihara, M., Sugano, M., Yamamoto, R., Tanaka, S., Fujita, A., Kogure, Y., Seki, Y., Mogi, A., Oyama, T., Minato, K., Asao, T., & Kaira, K. (2019). Clinical Significance of Various Drug-Sensitivity Markers in Patients with Surgically Resected Pulmonary Pleomorphic Carcinoma. Cancers, 11(11), . https://doi.org/10.3390/cancers11111636
Imai, Hisao, et al. "Clinical Significance of Various Drug-Sensitivity Markers in Patients with Surgically Resected Pulmonary Pleomorphic Carcinoma." Cancers vol. 11,11 (2019). doi: https://doi.org/10.3390/cancers11111636
Imai H, Shimizu K, Kawashima O, Endoh H, Imaizumi K, Goto Y, Kamiyoshihara M, Sugano M, Yamamoto R, Tanaka S, Fujita A, Kogure Y, Seki Y, Mogi A, Oyama T, Minato K, Asao T, Kaira K. Clinical Significance of Various Drug-Sensitivity Markers in Patients with Surgically Resected Pulmonary Pleomorphic Carcinoma. Cancers (Basel). 2019 Oct 24;11(11). doi: 10.3390/cancers11111636. PMID: 31653009; PMCID: PMC6895922.
Copy
Download .nbib